INTERNATIONAL PATENT: NEXEL CO., LTD., (주)넥셀 FILES APPLICATION FOR "METHOD FOR PRODUCING IN VITRO DISEASE SIMULATION MODEL IN WHICH ADULT ACUTE MYOCARDIAL INFARCTION AND HEART FAILURE DISEASES ARE INDUCED BY ISCHEMIA-REPERFUSION INJURY USING HUMAN PLURIPOTENT STEM CELL-DERIVED CARDIAC ORGANOID AND IN VITRO DISEASE SIMULATION MODEL PRODUCED THEREBY"

GENEVA, June 3 -- NEXEL CO., LTD. (8floor, 7floor, 55 Magok-dong-roGangseo-guSeoul 02580), (주)넥셀 (서울특별시강서구마곡동로 55, 7층, 8층) filed a patent application (PCT/KR2024/018773) for "METHOD FOR PRODUCING IN VITRO DISEASE SIMULATION MODEL IN WHICH ADULT ACUTE MYOCARDIAL INFARCTION AND HEART FAILURE DISEASES ARE INDUCED BY ISCHEMIA-REPERFUSION INJURY USING HUMAN PLURIPOTENT STEM CELL-DERIVED CARDIAC ORGANOID, AND IN VITRO DISEASE SIMULATION MODEL PRODUCED THEREBY" on Nov 25, 2024. With publication no. WO/2025/110825, the details related to the patent application was published on May 30, 2025.

Notably, the patent application was subm...